MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host its semi-annual Biotech and Pharma Investor Conference in New York City, NY on September 18-19, 2024.  The National Institutes of Health and O'Melveny Law Firm will be presenting sponsors of the event.

 

The conference is expected to attract 125+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.

 

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.

​

Speakers include:

​Greg Simon, Former President of the Biden Cancer Initiative and Former Head of Regulatory Affairs for Pfizer

Dennis Purcell, Founder, Aisling Capital and Former Managing Director of Healthcare Investment Banking at JP Morgan H&Q

Dr. Michael Baran, Partner at Pfizer Ventures and Executive Director, Worldwide Business Development at Pfizer

Ario Arabi, Executive Director, Business Development & Licensing, Novartis

Dr. David Danar, Investment Committee Member, Catalytic Impact Foundation

Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH

Dr. Michael Salgaller, Director of the Invention Development and Marketing Unit, NCI

Nate Gallon, Partner, O'Melveny

Geoff Kuziemko, Partner, O'Melveny

David Ribner, Partner, O'Melveny